Glioblastoma

• An interventional, multicenter, and international phase 1/2, light-dose-escalation study to investigate the safety and feasibility of intrao … Recruitment ended
  2025-520563-41-00 7 2025-09-29 "High-grade glioma Glioblastoma"
• Trial Designed To Evaluate Multiple Regimens In Newly Diagnosed and Recurrent Glioblastoma (GBM) Recruitment ended
  2024-511452-40-00 10 2025-09-12 "Oncology - Glioblastoma (GBM)"
• Phase I/II study of AGuIX nanoparticles with radiotherapy plus concomitant Temozolomide in the treatment of newly diagnosed glioblastoma Recruitment ended
  2024-517114-15-00 7 2025-03-07 "newly diagnosed gliblastoma"
• Phase Ib Dose Finding Study of [177Lu]Lu-NeoB in Combination with RT and TMZ in Newly Diagnosed Glioblastoma and as a Single Agent in Recurr … Recruitment ended
  2022-502134-10-00 3 2024-05-15
• A phase I clinical trial on combined (neo-)adjuvant intravenous plus intracranial administration of ipilimumab and nivolumab in recurrent gl … Recruitment ended
  2023-508278-26-01 7 2024-04-05 "glioblastoma"
• A clinical study to determine the dose and assess safety and efficacy of radioimmuntherapy in patients with glioblastoma, where Lutetium 177 … Recruitment ended
  2024-513638-39-00 1 2022-10-17 "Surgically treated high grade glioma after concomitant radio"
• Clinical trial to evaluate the effects of chemotherapy with anthracycline, after radiotherapy, in a group of pediatric and young adult patie … Recruitment ended
  2024-519135-41-00 4 2022-06-21
• A Dose Finding Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination with Standard of Care and in Recurrent Glioblasto … Recruitment ended
  2023-506719-17-00 3 2022-05-10
• Imaging Perfusion Restrictions from Extracellular Solid Stress - An open-label losartan study Recruitment ended
  2023-507575-22-00 4 2019-09-25 "Glioblastoma - newly diagnosed and recurrent tumors (Study A"
• An efficacy and safety study of 2-OHOA in patients with glioblastoma Recruitment ended
  2024-511542-39-00 10 2019-09-16 "Newly diagnosed primary glioblastoma multiforme (ndGBM)"
• Phase III randomised trial evaluating chemotherapy early treatment intensification with temozolomide in adults present with a glioblastoma Recruitment ended
  2022-500451-23-00 5 2019-03-18 "Adults with a de novo glioblastoma"
• Trial on efficacy and safety of vaccination of newly diagnosed glioblastoma patients with the patient's own immune cells. Recruitment ended
  2024-514820-18-00 4 2018-03-07 "newly diagnosed glioblastoma"
• Clinical Trial Evaluating Safety of 5-Aminolevulinic Acid (5-ALA) Combined With Ultrasound for Sonodynamic Therapy (SDT) in Patients With Ne … Ended
  2023-509238-20-00 4 2025-11-21 "High grade glioma"
• Phase Ib Clinical Trial to Evaluate the Safety Profile of the Combination Tilray FS Oral Solution T10:C10 with Temozolomide and Radiotherapy … Ended
  2024-515546-16-00 3 2024-08-27
• A study to determine how BI 907828 (Brigimadlin) is taken up in the tumor (Phase 0) and to determine the highest dose of BI 907828 (Brigimad … Ended
  2023-506409-20-00 3 2023-11-24
• A dose-escalation and expansion study of the safety and pharmacokinetics of XB002 as single-agent and combination therapy in subjects with i … Ended
  2023-508267-69-00 3 2023-08-11 "Subjects with Aadvanced solid tumors for whom life-prolongin"
• A study to see how well CVGBM vaccine works at different doses and how safe it is in patients who had surgery for glioblastoma or astrocytom … Ended
  2022-501423-25-00 7 2023-05-05 "Surgically Resected Glioblastoma (GBM) or Astrocytoma with a"
• Study to assess safety and identify dose of ribociclib in combination of temozolomide and topotecan (TOTEM) in patients (12 months – 21 year … Ended
  2024-512095-35-00 9 2022-12-27 "Relapsed or refractory neuroblastoma and other solid tumors "
• Regorafenib in combination with temozolomide with or without radiotherapy in patients with newly diagnosed MGMT-Methylated, IDH wild-type gl … Ended
  2024-514424-16-00 3 2022-07-04 "MGMT-Methylated, IDH wild-type glioblastoma"
• Study to evaluate the addition of an experimental drug, CC-90010, to the usual treatment of brain cancer after surgery Ended
  2024-511171-15-00 3 2020-07-06 "Subjects with newly diagnosed WHO Grade IV glioblastoma (ndG"
• A clinical gene therapy study with hematopoietic stem cells for the treatment of patients suffering from a malignant neoplasm of the central … Ended
  2023-510299-29-00 7 2019-03-13 "Glioblastoma multiforme"

Showing 25–45 of 45 trials